Article

High Frequency Actionable Pathogenic Exome Mutations in an Average-Risk Cohort

2017-06-18

Abstract excerpt

Whole exome sequencing (WES) is increasingly utilized in both clinical and non-clinical settings, but little is known about the utility of WES in healthy individuals. In order to determine the frequency of both medically actionable and non-actionable but medically relevant exome findings in the general population we assessed the exomes of 70 participants who have been extensively characterized over the past severa...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: c14a38b0-a42f-5e81-9d78-73b512ad2d72
DOI: 10.1101/151225

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

High Frequency Actionable Pathogenic Exome Mutations in an Average-Risk CohortDOI 10.1101/151225Read

Actionable, pathogenic incidental findings in 1,000 participants' exomes.Semantic proximity Read

Frequency and spectrum of actionable pathogenic secondary findings in 196 Korean exomes.Semantic proximity Read

Actionable exomic incidental findings in 6503 participants: challenges of variant classification.Semantic proximity Read

Medically Actionable Secondary Findings from Whole Exome Sequencing (WES) Data in a Sample of 3,972 IndividualsSemantic proximity Read

Exploring the landscape of pathogenic genetic variation in the ExAC population database: insights of relevance to variant classification.Semantic proximity Read

Frequency and management of medically actionable incidental findings from genome and exome sequencing data: a systematic review.Semantic proximity Read

Frequency and spectrum of actionable pathogenic secondary findings in Taiwanese exomes.Semantic proximity Read

Assessment of incidental findings in 232 whole-exome sequences from the Baylor-Hopkins Center for Mendelian Genomics.Semantic proximity Read

Clinical whole-exome sequencing for the diagnosis of mendelian disorders.Semantic proximity Read

Physician-directed genetic screening to evaluate personal risk for medically actionable disorders: a large multi-center cohort study.Semantic proximity Read

Genome-first evaluation with exome sequence and clinical data uncovers underdiagnosed genetic disorders in a large healthcare system.Semantic proximity Read

Pathogenic variants for Mendelian and complex traits in exomes of 6,517 European and African Americans: implications for the return of incidental results.Semantic proximity Read